Killing the hypnozoite - drug discovery approaches to prevent relapse in Plasmodium vivax

被引：77
作者：
Campo, Brice [1 ]
Vandal, Omar [2 ]
Wesche, David L. [2 ,3 ]
Burrows, Jeremy N. [1 ]
机构：
[1] Med Malaria Venture, Geneva, Switzerland
[2] Bill & Melinda Gates Fdn, Seattle, WA USA
[3] Great Lakes Drug Dev Certara, Princeton, NJ USA
来源：
PATHOGENS AND GLOBAL HEALTH | 2015年 / 109卷 / 03期
关键词：
Plasmodium vivax; Radical cure; Hypnozoite; Strategy; Drug discovery assays; IN-VITRO CULTURE; LIVER STAGE; MALARIA PARASITES; EXOERYTHROCYTIC PARASITES; ANTIMALARIAL ACTIVITY; FALCIPARUM-MALARIA; HUMAN HEPATOCYTES; RADICAL CURE; MOUSE MODELS; PRIMAQUINE;
D O I：
10.1179/2047773215Y.0000000013
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
The eradication of malaria will only be possible if effective, well-tolerated medicines kill hypnozoites in vivax and ovale malaria, and thus prevent relapses in patients. Despite progress in the 8-aminoquinoline series, with tafenoquine in Phase III showing clear benefits over primaquine, the drug discovery challenge to identify hypnozoiticidal or hypnozoite-activating compounds has been hampered by the dearth of biological tools and assays, which in turn has been limited by the immense scientific and logistical challenges associated with accessing relevant human tissue and sporozoites. This review summarises the existing drug discovery series and approaches concerning the goal to block relapse.
引用
收藏
页码：107 / 122
页数：16
相关论文
共 115 条
  • [21] The Activities of Current Antimalarial Drugs on the Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites
    Delves, Michael
    Plouffe, David
    Scheurer, Christian
    Meister, Stephan
    Wittlin, Sergio
    Winzeler, Elizabeth A.
    Sinden, Robert E.
    Leroy, Didier
    [J]. PLOS MEDICINE, 2012, 9 (02)
  • [22] Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures
    Dembele, Laurent
    Franetich, Jean-Francois
    Lorthiois, Audrey
    Gego, Audrey
    Zeeman, Anne-Marie
    Kocken, Clemens H. M.
    Le Grand, Roger
    Dereuddre-Bosquet, Nathalie
    van Gemert, Geert-Jan
    Sauerwein, Robert
    Vaillant, Jean-Christophe
    Hannoun, Laurent
    Fuchter, Matthew J.
    Diagana, Thierry T.
    Malmquist, Nicholas A.
    Scherf, Artur
    Snounou, Georges
    Mazier, Dominique
    [J]. NATURE MEDICINE, 2014, 20 (03) : 307 - 312
  • [23] Towards an In Vitro Model of Plasmodium Hypnozoites Suitable for Drug Discovery
    Dembele, Laurent
    Gego, Audrey
    Zeeman, Anne-Marie
    Franetich, Jean-Francois
    Silvie, Olivier
    Rametti, Armelle
    Le Grand, Roger
    Dereuddre-Bosquet, Nathalie
    Sauerwein, Robert
    van Gemert, Geert-Jan
    Vaillant, Jean-Christophe
    Thomas, Alan W.
    Snounou, Georges
    Kocken, Clemens H. M.
    Mazier, Dominique
    [J]. PLOS ONE, 2011, 6 (03):
  • [24] Use of a Rhesus Plasmodium cynomolgi Model to Screen for Anti-Hypnozoite Activity of Pharmaceutical Substances
    Deye, Gregory A.
    Gettayacamin, Montip
    Hansukjariya, Pranee
    Im-erbsin, Rawiwan
    Sattabongkot, Jetsumon
    Rothstein, Yarrow
    Macareo, Louis
    Fracisco, Susan
    Bennett, Kent
    Magill, Alan J.
    Ohrt, Colin
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2012, 86 (06) : 931 - 935
  • [25] Gametocyte Dynamics and the Role of Drugs in Reducing the Transmission Potential of Plasmodium vivax
    Douglas, Nicholas M.
    Simpson, Julie A.
    Phyo, Aung Pyae
    Siswantoro, Hadjar
    Hasugian, Armedy R.
    Kenangalem, Enny
    Poespoprodjo, Jeanne Rini
    Singhasivanon, Pratap
    Anstey, Nicholas M.
    White, Nicholas J.
    Tjitra, Emiliana
    Nosten, Francois
    Price, Ric N.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (05) : 801 - 812
  • [26] The anaemia of Plasmodium vivax malaria
    Douglas, Nicholas M.
    Anstey, Nicholas M.
    Buffet, Pierre A.
    Poespoprodjo, Jeanne R.
    Yeo, Tsin W.
    White, Nicholas J.
    Price, Ric N.
    [J]. MALARIA JOURNAL, 2012, 11
  • [27] Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta)
    Dow, Geoffrey S.
    Gettayacamin, Montip
    Hansukjariya, Pranee
    Imerbsin, Rawiwan
    Komcharoen, Srawuth
    Sattabongkot, Jetsumon
    Kyle, Dennis
    Milhous, Wilbur
    Cozens, Simon
    Kenworthy, David
    Miller, Anne
    Veazey, Jim
    Ohrt, Colin
    [J]. MALARIA JOURNAL, 2011, 10
  • [28] Evaluation of the safety and tolerability of a short higher-dose primaquine regimen for presumptive anti-relapse therapy in healthy subjects
    Ebringer, Andrew
    Heathcote, Gary
    Baker, Joanne
    Waller, Michael
    Shanks, G. Dennis
    Edstein, Michael D.
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2011, 105 (10) : 568 - 573
  • [29] Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity
    Epstein, J. E.
    Tewari, K.
    Lyke, K. E.
    Sim, B. K. L.
    Billingsley, P. F.
    Laurens, M. B.
    Gunasekera, A.
    Chakravarty, S.
    James, E. R.
    Sedegah, M.
    Richman, A.
    Velmurugan, S.
    Reyes, S.
    Li, M.
    Tucker, K.
    Ahumada, A.
    Ruben, A. J.
    Li, T.
    Stafford, R.
    Eappen, A. G.
    Tamminga, C.
    Bennett, J. W.
    Ockenhouse, C. F.
    Murphy, J. R.
    Komisar, J.
    Thomas, N.
    Loyevsky, M.
    Birkett, A.
    Plowe, C. V.
    Loucq, C.
    Edelman, R.
    Richie, T. L.
    Seder, R. A.
    Hoffman, S. L.
    [J]. SCIENCE, 2011, 334 (6055) : 475 - 480
  • [30] Enantioselective metabolism of primaquine by human CYP2D6
    Fasinu, Pius S.
    Tekwani, Babu L.
    Nanayakkara, N. P. Dhammika
    Avula, Bharathi
    Herath, H. M. T. Bandara
    Wang, Yan-Hong
    Adelli, Vijender R.
    Elsohly, Mahmoud A.
    Khan, Shabana I.
    Khan, Ikhlas A.
    Pybus, Brandon S.
    Marcsisin, Sean R.
    Reichard, Gregory A.
    McChesney, James D.
    Walker, Larry A.
    [J]. MALARIA JOURNAL, 2014, 13
12345678910